ATS (ATS) 15th Annual Global Materials & Industrials Conference summary

Business overview and market focus

• Operates globally with $3B revenue, 7,000 employees, and presence in 20+ countries, providing automated manufacturing solutions across life sciences, food, consumer, and transportation sectors.

• Life sciences make up about half of business, with significant roles in medical devices, pharma, EV battery assembly, food processing, and clean energy.

• Focuses on regulated, low-cyclicality markets where quality is critical, such as life sciences, food, and energy.

• Recent years saw 24 acquisitions to expand technology and capabilities, aiming to provide holistic solutions.

Strategic transformation and growth

• Underwent a turnaround starting in 2007, divesting non-core assets and regaining market trust over a decade.

• Shifted to a decentralized, market-focused model under new CEO since 2017, emphasizing continuous improvement.

• Name change to ATS Corporation in 2022 reflected broader, more advanced capabilities and a focus on technology transfer.

• Growth strategy targets both organic and inorganic expansion, with a five-year CAGR of 19% including M&A.

Market trends and opportunities

• Nearshoring and supply chain de-risking are driving demand for automation, especially for new product launches and capacity scaling.

• Automation enables significant cost and margin improvements, as seen in case studies moving production from China to North America.

• Attractive markets for future expansion share traits of regulation, low cyclicality, and high quality requirements.